Influenza vaccine oculorespiratory syndrome incidence is reduced in HIV
- PMID: 21872629
- DOI: 10.1016/j.vaccine.2011.08.066
Influenza vaccine oculorespiratory syndrome incidence is reduced in HIV
Abstract
Clinical experience suggests Oculorespiratory Syndrome (ORS) following influenza vaccination is rare in HIV but this is not well evaluated. We assessed ORS incidence in a randomized influenza vaccine trial of HIV participants. The overall incidence was 0.8% suggesting that influenza vaccine ORS incidence is reduced in HIV.
Copyright © 2011 Elsevier Ltd. All rights reserved.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical